These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18312390)

  • 21. Melanoma and immunotherapy.
    Eggermont AM; Schadendorf D
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular-targeted therapies: lessons from years of clinical development.
    Rosa DD; Ismael G; Lago LD; Awada A
    Cancer Treat Rev; 2008 Feb; 34(1):61-80. PubMed ID: 17826917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy developments for pancreatic cancer.
    Bhattacharyya M; Lemoine NR
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):285-98. PubMed ID: 16549328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Target-based therapies in breast cancer: current status and future perspectives.
    Normanno N; Morabito A; De Luca A; Piccirillo MC; Gallo M; Maiello MR; Perrone F
    Endocr Relat Cancer; 2009 Sep; 16(3):675-702. PubMed ID: 19525314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New molecular targets and biological therapies in sarcomas.
    Scappaticci FA; Marina N
    Cancer Treat Rev; 2001 Dec; 27(6):317-26. PubMed ID: 11908925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translational research in melanoma.
    Tsai S; Sabel MS
    Surg Oncol Clin N Am; 2008 Apr; 17(2):391-419, ix-x. PubMed ID: 18375359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets.
    Motadi LR; Misso NL; Dlamini Z; Bhoola KD
    Int Immunopharmacol; 2007 Dec; 7(14):1934-47. PubMed ID: 18039530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New therapeutic targets in melanoma.
    Martí RM; Sorolla A; Yeramian A
    Actas Dermosifiliogr; 2012 Sep; 103(7):579-90. PubMed ID: 22261672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in the treatment of late stage melanoma.
    Walkington LA; Lorigan P; Danson SJ
    BMJ; 2013 Mar; 346():f1265. PubMed ID: 23460638
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel targets for therapy in paediatric oncology.
    Estlin EJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):141-50. PubMed ID: 12476788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy for metastatic melanoma: an overview and update.
    Boyle GM
    Expert Rev Anticancer Ther; 2011 May; 11(5):725-37. PubMed ID: 21554048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular markers of response to treatment for melanoma.
    Sznol M
    Cancer J; 2011; 17(2):127-33. PubMed ID: 21427556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel treatment strategies for malignant melanoma: a new beginning?
    Kasper B; D'Hondt V; Vereecken P; Awada A
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):16-22. PubMed ID: 17208006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications.
    Tortora G; Ciardiello F; Gasparini G
    Nat Clin Pract Oncol; 2008 Sep; 5(9):521-30. PubMed ID: 18594498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiangiogenic and antiapoptotic treatment in advanced melanoma.
    Nikolaou V; Stratigos A; Bafaloukos D; Katsambas A
    Clin Dermatol; 2013; 31(3):257-63. PubMed ID: 23608445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial review: targets for glioma treatment: from bench to bedside.
    Sanson M
    Curr Opin Oncol; 2008 Nov; 20(6):650-1. PubMed ID: 18841046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to develop a successful cancer drug--molecules to medicines or targets to treatments?
    Newell DR
    Eur J Cancer; 2005 Mar; 41(5):676-82. PubMed ID: 15763642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanoma.
    Eberle J; Fecker LF; Hossini AM; Kurbanov BM; Fechner H
    Exp Dermatol; 2008 Jan; 17(1):1-11. PubMed ID: 18095940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted therapy for uveal melanoma.
    Triozzi PL; Eng C; Singh AD
    Cancer Treat Rev; 2008 May; 34(3):247-58. PubMed ID: 18226859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Translation of recent advances and discoveries in molecular biology and immunology in the diagnosis and treatment of pancreatic cancer.
    Albo D; Farrow B; Berger DH
    Surg Oncol Clin N Am; 2008 Apr; 17(2):357-76, ix. PubMed ID: 18375357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.